Global Alliance for Rabies Control, 529 Humboldt St Suite One, Manhattan, KS 66502, USA.
Curr Opin Virol. 2012 Jun;2(3):309-14. doi: 10.1016/j.coviro.2012.03.007. Epub 2012 Apr 11.
Rabies vaccines have evolved from the first crude nerve tissue vaccines developed by Louis Pasteur and his colleagues in 1885. Currently, safe and efficacious rabies vaccines for humans and animals are produced in several cell culture systems with 10 vaccine regimens recommended by WHO and/or ACIP for pre-exposure and post-exposure prophylaxis in humans. Rabies vaccines are a critical component in the strategy to reduce the dog rabies, the cause of 98% of all global human rabies deaths. However, eliminating rabies in the reservoir animal species is not possible without an intersectoral approach including collaboration between animal and human health experts. There is an urgent need to establish national risk assessment systems in regions where surveillance is limited to non-existent.
狂犬病疫苗是由路易斯·巴斯德(Louis Pasteur)及其同事于 1885 年首次开发的原始神经组织疫苗演变而来的。目前,有几种细胞培养系统可用于生产安全有效的人类和动物狂犬病疫苗,世界卫生组织(WHO)和/或美国免疫咨询委员会(ACIP)推荐了 10 种疫苗方案,用于人类的暴露前和暴露后预防。狂犬病疫苗是减少犬狂犬病的策略中的重要组成部分,犬狂犬病是导致全球 98%人类狂犬病死亡的原因。然而,如果没有包括动物和人类卫生专家之间合作的跨部门方法,就不可能消除储存宿主动物中的狂犬病。因此,在监测仅限于不存在的地区,迫切需要建立国家风险评估系统。